Acid-Peptic Disease Drugs: The Parietal Cell Explained

Peptic ulcers and reflux come down to one cell — the gastric parietal cell — and the acid it pumps. Every acid-suppressing drug works at one labelled point on this cell, so the diagram below is the topic.

1. Proton-pump inhibitors (PPIs) — the most effective

Omeprazole, pantoprazole, esomeprazole irreversibly block the H⁺/K⁺ ATPase — the final common step of acid secretion — so they outperform all others. Best taken before food.

• Uses: GERD, peptic ulcer, H. pylori regimens, NSAID protection, Zollinger-Ellison syndrome.
• Long-term cautions: ↓ B₁₂/magnesium/calcium absorption, C. difficile risk, rebound acid on stopping.

2. H₂-receptor blockers

Famotidine (ranitidine was withdrawn over NDMA) blocks histamine at the H₂ receptor — effective, especially for nocturnal acid, but weaker than PPIs and prone to tolerance.

3. Antacids

Magnesium (laxative) and aluminium (constipating) salts, often combined, neutralise acid already secreted — fast symptom relief, no healing effect. They bind other drugs, so separate dosing.

4. Mucosal protectants

• Sucralfate — coats the ulcer base.
• Misoprostol — a prostaglandin analogue that restores mucosal defence; useful for NSAID ulcers but contraindicated in pregnancy (abortifacient).
• Bismuth — protective and mildly anti-H. pylori.

5. H. pylori eradication

Most peptic ulcers are caused by H. pylori. Standard triple therapy = a PPI + two antibiotics (clarithromycin + amoxicillin or metronidazole) for 7–14 days; eradication prevents recurrence.

Exam tip: PPIs act at the final step (the pump), which is exactly why they are the most powerful acid suppressors — a favourite one-liner. And always treat the cause: test for and eradicate H. pylori.

Anchor all five classes to their point on the parietal cell, remember that PPIs hit the final common pathway, and acid-peptic pharmacology becomes one clean, memorable picture.